Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations - A proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations

Pediatric and Developmental Pathology

Volumn 12, Issue 3, 2009, Pages 187-194

  Castro, Eumenia Costa Da Cunha ^a   Galambos, Csaba ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

CD31; CD34; Lymphatic malformation; Prox 1; Vascular malformations; VEGFR3

Indexed keywords

CD31 ANTIGEN; CD34 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2-40; PROSPERO RELATED HOMEOBOX GENE 1 ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3 ANTIBODY;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHATIC SYSTEM DISEASE; MALE; NEWBORN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAINING;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD31; ANTIGENS, CD34; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIUM, LYMPHATIC; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LYMPHATIC VESSELS; MALE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; VASCULAR MALFORMATIONS;

EID: 66749171715     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-05-0471.1     Document Type: Article

References (29)

1. Hamoir M, Plouin-Gaudon I, Rombaux P, et al. Lymphatic malformations of the head and neck: a retrospective review and a support for staging. Head Neck 2001;23:326-337. (Pubitemid 32234112)
2. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg 2000;37:517-584.
3. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg Mar 1982;69:412-422. (Pubitemid 12191292)
4. Kennedy TL. Cystic hygroma-lymphangioma: a rare and still unclear entity. Laryngoscope 1989;99:1-10. (Pubitemid 19264492)
5. Gallagher PG, Mahoney MJ, Gosche JR. Cystic hygroma in the fetus and newborn. Semin Perinatol 1999;23:341-356. (Pubitemid 29399389)
6. Fogt F, Pascha TL, Zhang PJ, et al. Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. Int J Mol Med 2004;13:211-214.
7. Fogt F, Zimmerman RL, Ross HM, Daly T, Gausas RE. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncology Rep 2004;11:47-50.
8. Gausas RE, Daly T, Fogt F. D2-40 expression demonstrates lymphatic vessel characteristics in the dural portion of the optic nerve sheath. Ophthal Plastic Reconstr Surg 2007;23:32-36. (Pubitemid 46146895)
9. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod Pathol 2002;15:434-440. (Pubitemid 34326952)
10. Kahn HJ, Marks A. A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Investig 2002;82:1255-1257.
11. Kaiserling E. Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology. Pathologe 2004;25:362-374. (Pubitemid 39265399)
12. Pedica F, Ligorio C, Tonelli P, Bartolini S, Baccarini P. Lymphangiogenesis in Crohn's disease: an immunohistochemical study using monoclonal antibody D2-40. Virchows Arch 2008;452:57-63.
13. Dumoff KL, Chu C, Xu X, et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol 2005;18:97-104. (Pubitemid 40128101)
14. Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol 2005;8:181-189. (Pubitemid 40895696)
15. Mäkinen T, Norrmén C, Petrova TV. Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci 2007;64:1915-1929. (Pubitemid 47094431)
16. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801. (Pubitemid 29234556)
17. Partanen TA, Paavonen K. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Microsc Res Tech 2001;55:108-121. (Pubitemid 32990029)
18. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-778. (Pubitemid 29446894)
19. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-298. (Pubitemid 26029207)
20. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-3570.
21. Petrova TV, Bono P, Holnthoner W, et al. VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors. Cancer Cell 2008;13:554-556.
22. Baluk P, McDonald DM. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann NY Acad Sci 2008;1131:1-12.
23. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 2000;156:1499-1504. (Pubitemid 30646689)
24. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999;86:2406-2412. (Pubitemid 30010384)
25. Silvestri F, Banavali S, Baccarani M, Preisler HD. The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applications. Haematologica 1992;77:265-273.
26. Stella CC, Cazzola M, De Fabritiis P, et al. CD34-positive cells: biology and clinical relevance. Haematologica 1995;80:367-387.
27. Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002;16:1271-1273.
28. Fiedler U, Christian S, Koidl S, et al. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors. Am J Pathol 2006;168:1045-1053. (Pubitemid 43327754)
29. Franke FE, Steger K, Marks A, et al. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas. J Cutan Pathol 2004;31:362-367. (Pubitemid 38530120)